Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:FGMCNASDAQ:KLDONASDAQ:STIXNASDAQ:VRAR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFGMCFG Merger II$9.87-0.1%$9.74$9.53▼$9.89$25.65MN/A32,342 shs13,111 shsKLDOKaleido Biosciences$0.00$0.00$0.00▼$0.07$4K-0.069,185 shs2,216 shsSTIXSemantix$0.00$0.28▼$4.77$23.73M-0.3752,087 shsN/AVRARThe Glimpse Group$1.25-6.0%$1.32$0.50▼$7.00$28M1.23828,367 shs77,179 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFGMCFG Merger II-0.10%+0.10%+0.92%+2.92%+1,021.59%KLDOKaleido Biosciences0.00%0.00%-50.00%-90.00%0.00%STIXSemantix0.00%0.00%0.00%0.00%-99.03%VRARThe Glimpse Group-6.02%-10.71%-10.71%-1.57%+25.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFGMCFG Merger IIN/AN/AN/AN/AN/AN/AN/AN/AKLDOKaleido BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ASTIXSemantixN/AN/AN/AN/AN/AN/AN/AN/AVRARThe Glimpse Group1.683 of 5 stars3.53.00.00.00.01.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFGMCFG Merger II 0.00N/AN/AN/AKLDOKaleido Biosciences 0.00N/AN/AN/ASTIXSemantix 0.00N/AN/AN/AVRARThe Glimpse Group 3.00Buy$2.62109.60% UpsideCurrent Analyst Ratings BreakdownLatest KLDO, FGMC, STIX, and VRAR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/24/2025VRARThe Glimpse GroupWestpark CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$2.625/22/2025VRARThe Glimpse GroupWestpark CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$2.62 ➝ $2.624/8/2025VRARThe Glimpse GroupWestpark CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$4.67 ➝ $2.62(Data available from 6/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFGMCFG Merger IIN/AN/AN/AN/AN/AN/AKLDOKaleido Biosciences$1.10M0.00N/AN/AN/A∞STIXSemantix$264.23M0.00N/AN/A$1.01 per share0.00VRARThe Glimpse Group$8.80M2.99N/AN/A$0.64 per share1.95Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFGMCFG Merger II-$30KN/A0.00∞N/AN/AN/AN/AN/AKLDOKaleido BiosciencesN/A-$2.24N/AN/AN/AN/AN/AN/AN/ASTIXSemantix-$63.61M-$0.81N/AN/AN/A-69.49%-45.45%-26.98%N/AVRARThe Glimpse Group-$6.39M-$0.37N/A∞N/A-74.05%-45.44%-35.42%N/ALatest KLDO, FGMC, STIX, and VRAR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q3 2025VRARThe Glimpse Group-$0.02-$0.07-$0.05-$0.07$1.50 million$1.42 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFGMCFG Merger IIN/AN/AN/AN/AN/AKLDOKaleido BiosciencesN/AN/AN/AN/AN/ASTIXSemantixN/AN/AN/AN/AN/AVRARThe Glimpse GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFGMCFG Merger IIN/A1.771.77KLDOKaleido BiosciencesN/AN/AN/ASTIXSemantixN/A1.611.61VRARThe Glimpse GroupN/A2.572.57Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFGMCFG Merger IIN/AKLDOKaleido Biosciences81.56%STIXSemantix40.12%VRARThe Glimpse Group21.41%Insider OwnershipCompanyInsider OwnershipFGMCFG Merger II20.20%KLDOKaleido Biosciences9.00%STIXSemantix35.50%VRARThe Glimpse Group21.47%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFGMCFG Merger II22.60 million2.07 millionNot OptionableKLDOKaleido Biosciences8042.62 million38.79 millionNot OptionableSTIXSemantix479.10 million51.02 millionNot OptionableVRARThe Glimpse Group20021.06 million16.54 millionOptionableKLDO, FGMC, STIX, and VRAR HeadlinesRecent News About These CompaniesThe Glimpse Group (NASDAQ:VRAR) Given Buy Rating at Westpark Capital2 hours ago | americanbankingnews.comEarnings call transcript: Glimpse Group Q3 2025 shows positive cash flowMay 16, 2025 | investing.comThe Glimpse Group, Inc. (NASDAQ:VRAR) Q3 2025 Earnings Call TranscriptMay 16, 2025 | insidermonkey.comGlimpse Group signals $10M-$11M FY25 revenue outlook and potential stock buyback amid Spatial Core momentumMay 15, 2025 | msn.comThe Glimpse Group, Inc. (VRAR) Q3 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comThe Glimpse Group Reports Q3 Fiscal Year 2025 Financial ResultsMay 15, 2025 | accessnewswire.comAThe Glimpse Group to Announce Q3 Fiscal Year 2025 Financial Results On Thursday, May 15, 2025 at 9am Eastern TimeMay 9, 2025 | accessnewswire.comARevealia Breast(TM) Offers Glimpse Into the Future of Early Cancer Detection With a Simple Cheek SwabMay 7, 2025 | accessnewswire.comATrip.com: Labor Day Surge Gives A Glimpse Into Its Growth TrajectoryApril 30, 2025 | seekingalpha.comGlimpse Group’s Brightline Interactive delivers immersive simulator to U.S. NavyApril 23, 2025 | markets.businessinsider.comBrightline Interactive Successfully Delivers First Full-Motion Immersive Simulator to the U.S. NavyApril 22, 2025 | accessnewswire.comAThe Glimpse Group, Inc. (NASDAQ:VRAR) Q2 2025 Earnings Call TranscriptFebruary 17, 2025 | insidermonkey.comGlimpse Group (NASDAQ:VRAR) Is In A Good Position To Deliver On Growth PlansFebruary 15, 2025 | finance.yahoo.comThe Glimpse Group outlines $11M+ FY2025 revenue target with strong Q4 projectionsFebruary 13, 2025 | seekingalpha.comThe Glimpse Group, Inc. (VRAR) Q2 2025 Earnings Call TranscriptFebruary 13, 2025 | seekingalpha.comThe Glimpse Group Reports Q2 Fiscal Year 2025 Financial Results - 50% Increase in Revenue and Positive EBITDA, Positive Cash Flow & Positive Net IncomeFebruary 13, 2025 | accessnewswire.comAThe Glimpse Group to Announce Q2 Fiscal Year 2025 Financial Results On Thursday, February 13, 2025 at 9am Eastern TimeFebruary 7, 2025 | accessnewswire.comAIs The Glimpse Group (VRAR) the Best Augmented Reality Stock to Invest in Under $10?February 4, 2025 | msn.comGlimpse President and CEO Lyron Bentovim To Be Interviewed on Schwab Network’s “Trading 360 ...January 17, 2025 | bakersfield.comBGlimpse President and CEO Lyron Bentovim To Be Interviewed on Schwab Network's “Trading 360 with Nicole Petallides” On The Topic of Immersive Technology, Spatial Computing, AI and Key PartnershipsJanuary 17, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeKLDO, FGMC, STIX, and VRAR Company DescriptionsFG Merger II NASDAQ:FGMC$9.87 -0.01 (-0.10%) As of 06/25/2025 03:31 PM EasternFG Merger II Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on September 20, 2023 and is headquartered in Itasca, IL.Kaleido Biosciences NASDAQ:KLDO$0.0001 0.00 (0.00%) As of 06/24/2025 02:15 PM EasternKaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.Semantix NASDAQ:STIXSemantix, Inc., together with its subsidiaries, provides end-to-end proprietary Software as a Service (SaaS) data platform in Latin America and the United States. The company offers SDP, a multi-cloud SaaS data platform that provides data integration, data operations, machine learning operations, data governance, data sharing, and data visualization for financial institutions; healthcare plans operators, health insurance brokers, hospitals, clinics, and imaging and diagnostics facilities; and retailers. It also sells third-party software licenses to the finance, retail, telecommunications, healthcare, industrials, and other sectors. In addition, the company offers artificial intelligence and data analytics services, including consulting, cloud monitoring, data integration, data science, and data engineering. The company was founded in 2010 and is based in São Paulo, Brazil.The Glimpse Group NASDAQ:VRAR$1.25 -0.08 (-6.02%) Closing price 06/25/2025 04:00 PM EasternExtended Trading$1.25 0.00 (0.00%) As of 06/25/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Glimpse Group, Inc., a virtual reality (VR) and augmented reality (AR) platform company, provides enterprise-focused software, services, and solutions in the United States. It offers QReal, a software that creates and distributes photorealistic 3D interactive digital models and experiences in AR; Immersive Health Group, a VR/AR platform for evidence-based and outcome driven healthcare solutions; and Foretell Reality, a social VR platform for behavioral health, support groups, collaboration, and soft skills training. The company also provides Glimpse Turkey for developing and creating 3D models for QReal; XR Terra that provides immersive technologies for teaching courses and training; Sector 5 Digital for corporate immersive experiences and events; PulpoAR, an AR try-on technology that targets the beauty and cosmetics industry; and Brightline Interactive, which offers immersive and interactive experiences, training scenarios, and simulations for government and commercial customers. The company was incorporated in 2016 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside AeroVironment Will Hit New Highs This Year: Bull Flag Confirmed Uber and Tesla Surge on Robotaxis, Analyst Touts Texas Rides Palantir Stock Hits ATH, But Can the Rally Hold Without Volume? Costco at a Crossroads: Is the Next Move Higher or Lower? AST SpaceMobile's Signal Strengthens as Stock Nears Orbit Oracle Stock Boils Higher, $300 Price Target in Sight 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
